AT1314U1 - Fertiginfusionsset - Google Patents
Fertiginfusionsset Download PDFInfo
- Publication number
- AT1314U1 AT1314U1 AT0023796U AT23796U AT1314U1 AT 1314 U1 AT1314 U1 AT 1314U1 AT 0023796 U AT0023796 U AT 0023796U AT 23796 U AT23796 U AT 23796U AT 1314 U1 AT1314 U1 AT 1314U1
- Authority
- AT
- Austria
- Prior art keywords
- infusion
- ready
- infusion set
- set according
- thioctic acid
- Prior art date
Links
- 238000001802 infusion Methods 0.000 title claims abstract description 57
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims abstract description 19
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000019136 lipoic acid Nutrition 0.000 claims abstract description 19
- 229960002663 thioctic acid Drugs 0.000 claims abstract description 19
- 239000007924 injection Substances 0.000 claims description 10
- 238000002347 injection Methods 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 9
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 6
- 230000001681 protective effect Effects 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 4
- 229960000281 trometamol Drugs 0.000 claims description 4
- 239000003638 chemical reducing agent Substances 0.000 claims description 3
- 230000004927 fusion Effects 0.000 claims description 2
- 239000000644 isotonic solution Substances 0.000 claims description 2
- 229910017053 inorganic salt Inorganic materials 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 15
- 239000003978 infusion fluid Substances 0.000 abstract description 5
- 208000032131 Diabetic Neuropathies Diseases 0.000 abstract description 2
- 201000002342 diabetic polyneuropathy Diseases 0.000 abstract description 2
- 230000035807 sensation Effects 0.000 abstract description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- External Artificial Organs (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE29506604U DE29506604U1 (de) | 1995-04-25 | 1995-04-25 | Fertiginfusionsset |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT1314U1 true AT1314U1 (de) | 1997-03-25 |
Family
ID=8007014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0023796U AT1314U1 (de) | 1995-04-25 | 1996-04-24 | Fertiginfusionsset |
Country Status (9)
| Country | Link |
|---|---|
| AT (1) | AT1314U1 (nl) |
| BE (1) | BE1009699A6 (nl) |
| DE (1) | DE29506604U1 (nl) |
| ES (1) | ES2125800B1 (nl) |
| FR (1) | FR2733428B3 (nl) |
| GB (1) | GB2300121B (nl) |
| IT (2) | ITTO960094U3 (nl) |
| NL (1) | NL1002937C2 (nl) |
| PT (2) | PT9273T (nl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110296811A (zh) * | 2019-07-03 | 2019-10-01 | 湖南科技大学 | 一种雷诺实验装置颜色水流量两级调节装置 |
| CN113197845A (zh) * | 2020-12-16 | 2021-08-03 | 南京海融制药有限公司 | 一种硫辛酸氨丁三醇注射液及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1145307B (de) * | 1958-11-21 | 1963-03-14 | Galasyn Inc | Geraet fuer intravenoese Dauertropfinfusionen |
| DE2740811A1 (de) * | 1976-09-14 | 1978-03-16 | Sheldon S Zelitt | Parenterales anwendungsgeraet fuer intravenoese infusionen |
| US4248223A (en) * | 1978-03-20 | 1981-02-03 | Turner Charles R | Self-priming parenteral administering apparatus |
| US4192306A (en) * | 1978-08-21 | 1980-03-11 | Abbott Laboratories | Catheter placement assembly having axial and rotational alignment means |
| US4236515A (en) * | 1979-02-28 | 1980-12-02 | Abbott Laboratories | Equipment sets and system for the sequential administration of medical liquids at dual flow rates employing parallel secondary liquid tubing |
| US4534758A (en) * | 1983-07-15 | 1985-08-13 | Eli Lilly & Company | Controlled release infusion system |
| ATE70974T1 (de) * | 1987-12-04 | 1992-01-15 | Asta Pharma Ag | Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren. |
| ES2026058A6 (es) * | 1990-10-26 | 1992-04-01 | Parreno Rey Antonio | Sistema para infusion parenteral con recambio automatico de frasco. |
| DE9213914U1 (de) * | 1992-10-15 | 1992-12-03 | Asta Medica AG, 6000 Frankfurt | Ampulle und Infusionslösung von Thioctsäure in Form der wasserlöslichen Salze der Thioctsäure |
-
1995
- 1995-04-25 DE DE29506604U patent/DE29506604U1/de not_active Expired - Lifetime
-
1996
- 1996-04-19 GB GB9608214A patent/GB2300121B/en not_active Expired - Lifetime
- 1996-04-23 PT PT9273U patent/PT9273T/pt active IP Right Grant
- 1996-04-24 NL NL1002937A patent/NL1002937C2/nl not_active IP Right Cessation
- 1996-04-24 IT IT96TO000094U patent/ITTO960094U3/it unknown
- 1996-04-24 IT IT96TO000331A patent/IT1285056B1/it active IP Right Grant
- 1996-04-24 AT AT0023796U patent/AT1314U1/de not_active IP Right Cessation
- 1996-04-24 BE BE9600359A patent/BE1009699A6/fr not_active IP Right Cessation
- 1996-04-24 FR FR9605172A patent/FR2733428B3/fr not_active Expired - Lifetime
- 1996-04-24 ES ES09600928A patent/ES2125800B1/es not_active Expired - Fee Related
-
1997
- 1997-10-21 PT PT102071A patent/PT102071B/pt active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ES2125800A1 (es) | 1999-03-01 |
| PT9273T (pt) | 1997-06-30 |
| ITTO960331A1 (it) | 1997-10-24 |
| FR2733428B3 (fr) | 1997-06-13 |
| ITTO960331A3 (it) | 1997-10-24 |
| PT102071A (pt) | 1998-07-31 |
| GB2300121A (en) | 1996-10-30 |
| ITTO960094U3 (it) | 1997-10-24 |
| ES2125800B1 (es) | 1999-10-01 |
| GB2300121B (en) | 1998-12-23 |
| GB9608214D0 (en) | 1996-06-26 |
| DE29506604U1 (de) | 1995-06-14 |
| NL1002937A1 (nl) | 1996-10-28 |
| BE1009699A6 (fr) | 1997-07-01 |
| PT102071B (pt) | 1999-09-30 |
| FR2733428A1 (fr) | 1996-10-31 |
| NL1002937C2 (nl) | 1998-12-22 |
| IT1285056B1 (it) | 1998-06-03 |
| ITTO960331A0 (it) | 1996-04-24 |
| ITTO960094V0 (it) | 1996-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69519300T2 (de) | Stabiles arzneimittel enthaltend oxaliplatin | |
| DE69421689T2 (de) | Vorrichtung zur in-line verabreichung von drogen | |
| DE69402343T2 (de) | Katheter- und Nadeleinrichtung zum Verabreichen therapeutischer Lösungen | |
| EP3659594B1 (de) | Eine sterile lösung mit einem medizinischen wirkstoff enthaltende applikationsspritze und verfahren für deren bereitstellung | |
| DE3787177T2 (de) | Adapter zur Verbindung mit einer Ampulle zur Verabreichung eines Heilmittels. | |
| DE60215129T2 (de) | Esmolol-enthaltende zubereitungen | |
| EP3419598B1 (de) | Fosfomycin-formulierung zur parenteralen verabreichung | |
| EP0996462A1 (de) | Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine | |
| AT1314U1 (de) | Fertiginfusionsset | |
| EP1088565B1 (de) | Verschweisste Sterilverpackung mit einem Set für die intravesikale Instillation | |
| DE202012007199U1 (de) | Intrathekale pharmazeutische Baclofen-Dosierungsformen und dazugehöriges Abgabesystem | |
| CH690319A5 (de) | Fertiginfusionsset. | |
| DE3324964C2 (nl) | ||
| DE2749951C2 (nl) | ||
| DE3021911C2 (nl) | ||
| CA2496121A1 (en) | Stable formulations of hyaluronic acid for use in the therapeutic treatment of arthropathy | |
| DE102022114639A1 (de) | Trägerlösung zur Herstellung einer Arzneimittellösung in einer Spritze | |
| WO2023134805A1 (de) | Trägerlösung zur herstellung einer arzneimittellösung in einer spritze | |
| DE19925211B4 (de) | Kit zur Herstellung einer Formulierung von Paclitaxel | |
| EP0274708B1 (de) | Mittel zur Verabreichung bei Hypoglykämie | |
| DE10234784A1 (de) | Intravenös applizierbare, pharmazeutische Darreichungsform | |
| RU2777554C2 (ru) | Инъекция октреотида | |
| EP1393770A1 (de) | Medizinisches Arbeitsmittel | |
| DE69534696T2 (de) | Parenterale Fettemulsionen, die EDTA als Konservierungsmittel enthalten | |
| EP4268805A1 (de) | Fosfomycin-formulierung zur parenteralen verabreichung und herstellungsverfahren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MN9K | Cancelled due to lapse of time |